Cargando…
DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells
Epithelial ovarian cancer (EOC) is one of the most lethal gynecological malignancies and is known to be associated with the accumulation of various genetic and epigenetic alterations. As a member of the human histone-lysine N-methyltransferase SETD1A (SET1)/histone-lysine N-methyltransferase 2A (MLL...
Autores principales: | Zhang, Lili, Zhang, Shuguang, Li, Aihua, Zhang, Anqi, Zhang, Shiqian, Chen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202113/ https://www.ncbi.nlm.nih.gov/pubmed/30221689 http://dx.doi.org/10.3892/ijmm.2018.3869 |
Ejemplares similares
-
DPY30 regulates cervical squamous cell carcinoma by mediating epithelial–mesenchymal transition (EMT)
por: He, Feng-xi, et al.
Publicado: (2019) -
Roles of DPY30 in the Proliferation and Motility of Gastric Cancer Cells
por: Lee, Yong Joo, et al.
Publicado: (2015) -
MicroRNA-320a Promotes Epithelial Ovarian Cancer Cell Proliferation and Invasion by Targeting RASSF8
por: Zhang, Lili, et al.
Publicado: (2021) -
Loss of E-cadherin and epithelial to mesenchymal transition is not required for cell motility in tissues or for metastasis
por: Liu, Xiang, et al.
Publicado: (2014) -
Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts
por: Tisza, Michael J., et al.
Publicado: (2016)